A multidisciplinary approach to assess erectile dysfunction in high-risk cardiovascular patients

被引:10
|
作者
Schwarz, ER [1 ]
Rastogi, S [1 ]
Rodriguez, JJ [1 ]
Kapur, V [1 ]
Sulemanjee, N [1 ]
Gupta, R [1 ]
Rosanio, S [1 ]
机构
[1] Univ Texas, Med Branch, Sch Med, Dept Internal Med,Div Cardiol, Galveston, TX 77555 USA
关键词
erectile dysfunction; cardiac disease; phosphodiesterase inhibitors;
D O I
10.1038/sj.ijir.3901427
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Erectile dysfunction (ED) is increasingly considered as one manifestation of systemic vascular disease. Accordingly, ED and coronary artery disease share mutual risk factors and frequently coexist. Sexual health is an important aspect of our patients' lives, and ED is a common concern of the cardiovascular patient. Despite this, sexual function is under-addressed in the cardiac patient. Even when this topic is broached by the primary care physician or urologist, ED frequently remains untreated due to safety concerns involving cardiac disease and other comorbidities. This article describes our experience with this unique patient population, as well as our approach to building a multidisciplinary clinic designed to specifically address the important issue of ED in the cardiac patient.
引用
收藏
页码:S37 / S43
页数:7
相关论文
共 50 条
  • [41] Multidisciplinary approach to coronary artery revascularization: Optimal strategy for high-risk patients
    Anderson, Devon
    Chen, Sarah
    Southard, Jeffrey
    Catrip-Torres, Jorge Manuel
    Kiaii, Bob
    JOURNAL OF CARDIAC SURGERY, 2022, 37 (09) : 2900 - 2902
  • [42] Heart rate and blood pressure interactions in the development of erectile dysfunction in high-risk cardiovascular patients (vol 21, pg 272, 2014)
    Kratz, Mario T.
    Mancia, Giuseppe
    EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY, 2015, 22 (07) : 950 - 950
  • [43] Erectile Dysfunction Predicts Cardiovascular Events in High Risk Patients Receiving Telmisartan, Ramipril or Both
    Boehm, Michael
    Baumhaekel, Magnus
    Teo, Keen
    Sleight, Peter
    Probstfleld, Jeffrey
    Gao, Peggy
    Mann, Johannes H.
    Diaz, Rafael
    Dagenais, Gilles R.
    Jennings, Garry L.
    Liu, Lisheng
    Jansky, Petr
    Yusuf, Salim
    CIRCULATION, 2009, 120 (18) : S475 - S475
  • [44] The cardiovascular polypill in high-risk patients
    Lafeber, Melvin
    Spiering, Wilko
    Singh, Kavita
    Guggilla, Rama K.
    Patil, Vinodvenkatesh
    Webster, Ruth
    EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY, 2012, 19 (06) : 1234 - 1242
  • [45] Cardiovascular profile in patients with erectile dysfunction
    Sramkova, T.
    Meluzin, J.
    Panovsky, R.
    Dragomirecka, E.
    Chvatalova, I
    Sramkova, K.
    Sutory, M.
    Pesl, M.
    JOURNAL OF SEXUAL MEDICINE, 2010, 7 : 418 - 418
  • [46] THE PATHOGENETIC BASIS FOR THE TREATMENT OF ERECTILE DYSFUNCTION IN PATIENTS WITH CARDIOVASCULAR RISK FACTORS
    Buziashvili, Y., I
    Naskhletashvili, V. M.
    Esilevsky, Y. M.
    Matskeplishvili, S. T.
    EUROPEAN UROLOGY SUPPLEMENTS, 2011, 10 (02) : 128 - 128
  • [47] Correlation between erectile dysfunction and cardiovascular risk factors in diabetic patients
    Filali, K. Bertal
    El Mghari, G.
    El Ansari, N.
    DIABETES & METABOLISM, 2011, 37 : A40 - A40
  • [48] Serum endocan as a predictive biomarker of cardiovascular risk in erectile dysfunction patients
    Elkamshoushi, Abdel Aal M.
    Hassan, Eman M.
    El Abd, Amr M.
    Hassan, Seham Z.
    Maher, Amer A.
    ANDROLOGIA, 2018, 50 (10)
  • [49] Assessment of cardiovascular risk in patients with erectile dysfunction - Focus on the diabetic patient
    Kloner, RA
    ENDOCRINE, 2004, 23 (2-3) : 125 - 129
  • [50] Psoriasis Patients to erectile Dysfunction Screen? Association with cardiovascular Risk and Depression
    不详
    HAUTARZT, 2016, 67 (08): : 591 - 591